FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »

FDA Rejects Pfizer's Lyrica - Visit Bulgaria

Visit Bulgaria
FDA Rejects Pfizer's Lyrica
Visit Bulgaria
Pfizer shares down three cents and standing at $18.58 at the close of Wednesday's regular trading session, lost an additional two cents in after-hours trading.

and more »